| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
KOBE, Japan—High-throughput assay specialist Carna Biosciences and chemical library company Enamine announced they would collaborate on the discovery and development of lead compounds against a targeted kinase.
 
The companies did not specify which kinase they had targeted other than to say that it was related to cancer research. Under the terms of the agreement, Enamine will develop kinase-focused libraries using computational docking techniques and Carna will screen these libraries using a variety of in-house assay systems.
 
Dr. Andrei Tolmachev, president and CEO of Enamine, sees the collaboration as a strong application of the complementary skill sets of each company. The companies expect to license any positive compounds arising from the screen to pharmaceutical companies for further development, says Kohichiro Yoshino, Carna president and CEO. Financial details of the collaboration were not released.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue